2.48
price up icon0.40%   0.010
after-market After Hours: 2.43 -0.05 -2.02%
loading
Atai Life Sciences N V stock is traded at $2.48, with a volume of 2.01M. It is up +0.40% in the last 24 hours and up +68.71% over the past month. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$2.47
Open:
$2.5
24h Volume:
2.01M
Relative Volume:
1.05
Market Cap:
$496.84M
Revenue:
$314.00K
Net Income/Loss:
$-40.23M
P/E Ratio:
-8.8571
EPS:
-0.28
Net Cash Flow:
$-84.71M
1W Performance:
+6.90%
1M Performance:
+68.71%
6M Performance:
+66.44%
1Y Performance:
+75.89%
1-Day Range:
Value
$2.34
$2.50
1-Week Range:
Value
$2.18
$2.64
52-Week Range:
Value
$1.03
$2.64

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Name
Atai Life Sciences N V
Name
Phone
49 89 2153 9035
Name
Address
WALLSTRASSE 16, BERLIN
Name
Employee
54
Name
Twitter
Name
Next Earnings Date
2024-12-11
Name
Latest SEC Filings
Name
ATAI's Discussions on Twitter

Compare ATAI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ATAI
Atai Life Sciences N V
2.48 464.78M 314.00K -40.23M -84.71M -0.28
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-18-24 Reiterated H.C. Wainwright Buy
Apr-03-24 Upgrade Maxim Group Hold → Buy
Nov-01-22 Initiated Loop Capital Buy
Nov-30-21 Initiated Maxim Group Buy
Nov-11-21 Initiated ROTH Capital Buy
Oct-18-21 Initiated H.C. Wainwright Buy
Sep-01-21 Initiated Jefferies Buy
Jul-13-21 Initiated Berenberg Buy
Jul-13-21 Initiated Canaccord Genuity Buy
Jul-13-21 Initiated Cantor Fitzgerald Buy
Jul-13-21 Initiated Citigroup Buy
Jul-13-21 Initiated Cowen Outperform
Jul-13-21 Initiated Credit Suisse Outperform
Jul-13-21 Initiated RBC Capital Mkts Sector Perform
Jul-08-21 Initiated Aegis Capital Buy
View All

Atai Life Sciences N V Stock (ATAI) Latest News

pulisher
Jun 05, 2025

ATAI and Beckley Psytech Set to Merge in Strategic All-Share Dea - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Regeneron makes obesity push; Atai, Alto ink brain drug deals - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders - Business Wire

Jun 03, 2025
pulisher
Jun 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, STRM, ATAI, STR on Behalf of Shareholders - PR Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock By Investing.com - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains buy rating on atai Life Sciences stock - Investing.com

Jun 03, 2025
pulisher
Jun 02, 2025

Atai Life Sciences Merges With Beckley Psytech In Major Shakeup - Finimize

Jun 02, 2025
pulisher
Jun 02, 2025

atai Life Sciences and Beckley Psytech merging - Seeking Alpha

Jun 02, 2025
pulisher
Jun 02, 2025

Atai Life Sciences, Beckley Psytech to Merge in All-Stock Transaction - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Transcript : Atai Life Sciences N.V., Beckley Psytech LimitedM&A Call - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Thiel-Backed Psychedelic Drugmaker Atai to Combine With Beckley - Bloomberg

Jun 02, 2025
pulisher
Jun 02, 2025

ATAI and Beckley Psytech Plan Merger in Strategic All-Share Deal | ATAI Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies - Yahoo Finance

Jun 02, 2025
pulisher
May 30, 2025

Beckley Psytech & atai Life Sciences to combine expertise in pivotal merger - Mugglehead Magazine

May 30, 2025
pulisher
May 29, 2025

atai Life Sciences to Participate in Upcoming Investor Conferences - Yahoo

May 29, 2025
pulisher
May 27, 2025

2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com

May 27, 2025
pulisher
May 24, 2025

Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors - Benzinga

May 24, 2025
pulisher
May 23, 2025

atai Life Sciences N.V. (ATAI) Is Up 18.71% in One Week: What You Should Know - Nasdaq

May 23, 2025
pulisher
May 22, 2025

atai Life Sciences N.V. (ATAI) Just Flashed Golden Cross Signal: Do You Buy? - sharewise

May 22, 2025
pulisher
May 22, 2025

Is atai Life Sciences (ATAI) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

atai Life Sciences holds annual general meeting - Investing.com Australia

May 21, 2025
pulisher
May 21, 2025

atai Life Sciences holds annual general meeting By Investing.com - Investing.com India

May 21, 2025
pulisher
May 21, 2025

ATAI Life Sciences Approves Key Governance Changes - TipRanks

May 21, 2025
pulisher
May 21, 2025

Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

ATAI Life Sciences Sees Significant Rise in Borrow Rate | ATAI S - GuruFocus

May 21, 2025
pulisher
May 20, 2025

ATAI Stock Poised for Growth After Positive Phase 2a Data on BPL - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ATAI Stock Poised for Growth After Positive Phase 2a Data on BPL-003 | ATAI Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ATAI Life Sciences (ATAI) Shows Encouraging Mid-Stage Trial Resu - GuruFocus

May 20, 2025
pulisher
May 20, 2025

atai Life Sciences reports positive data from mid-stage depression trial - Seeking Alpha

May 20, 2025
pulisher
May 20, 2025

ATAI Reiterates a 'Buy' Rating with a Price Target of $10 | ATAI Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Atai Life Sciences Reports Positive Phase 2a Results for Treatment-Resistant Depression Drug - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

ATAI Life Sciences Reports Promising Findings from Depression Study | ATAI Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

atai reports positive phase 2a results for depression treatment By Investing.com - Investing.com UK

May 20, 2025
pulisher
May 20, 2025

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression - Yahoo Finance

May 20, 2025
pulisher
May 20, 2025

Psychedelic stocks up after FDA chief’s comments (ATAI:NASDAQ) - Seeking Alpha

May 20, 2025
pulisher
May 19, 2025

How Do Things Look For ATAI Life Sciences N.V (NASDAQ: ATAI) In The Short-Term? - Stocksregister

May 19, 2025
pulisher
May 16, 2025

Despite Lacking Profits Atai Life Sciences (NASDAQ:ATAI) Seems To Be On Top Of Its Debt - simplywall.st

May 16, 2025
pulisher
May 15, 2025

ATAI Explores Psychedelic Solutions for Veterans' Mental Health - GuruFocus

May 15, 2025
pulisher
May 15, 2025

ATAI Explores Psychedelic Solutions for Veterans' Mental Health | ATAI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Atai Life Sciences: Progress in Psychedelic Mental Health Treatments - TipRanks

May 15, 2025
pulisher
May 14, 2025

Will Atai Get A New Lease Of Life? - RTTNews

May 14, 2025
pulisher
May 14, 2025

Atai Life Sciences Reports First Quarter 2025 Financial Results - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

ATAI Reports Significant First Quarter Revenue Growth | ATAI Sto - GuruFocus

May 14, 2025
pulisher
May 14, 2025

ATAI Sees Financial Boost with Cash Reserves Rise | ATAI Stock N - GuruFocus

May 14, 2025
pulisher
May 14, 2025

ATAI Reports Significant First Quarter Revenue Growth | ATAI Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates - The Manila Times

May 14, 2025
pulisher
May 13, 2025

Certain Restricted stock units of Atai Life Sciences N.V. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Certain Options of Atai Life Sciences N.V. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

ATAI Begins Phase 2 Study for Social Anxiety Treatment | ATAI St - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Atai Life Sciences Announces First Patient Dosed In Phase 2 Study Of Emp-01 For The Treatment Of Social Anxiety Disorder - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder - Yahoo

May 13, 2025

Atai Life Sciences N V Stock (ATAI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Cap:     |  Volume (24h):